Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency.
Folate transport to the brain depends on ATP-driven folate receptor-mediated transport across choroid plexus epithelial cells. Failure of ATP production in Kearns-Sayre syndrome syndrome provides one explanation for the finding of low spinal fluid (CSF) 5-methyltetrahydrofolate (5MTHF) levels in this condition. Therefore, we suspect the presence of reduced folate transport across the blood-spinal fluid barrier in other mitochondrial encephalopathies. In the present patient with mitochondrial complex I encephalomyopathy a low 5-methyltetrahydrofolate level was found in the CSF. Serum folate receptor autoantibodies were negative and could not explain the low spinal fluid folate levels. The epileptic seizures did not respond to primidone monotherapy, but addition of ubiquinone-10 and radical scavengers reduced seizure frequency. Add-on treatment with folinic acid led to partial clinical improvement including full control of epilepsy, followed by marked recovery from demyelination of the brainstem, thalamus, basal ganglia and white matter. Cerebral folate deficiency is not only present in Kearns-Sayre syndrome but may also be secondary to the failure of mitochondrial ATP production in other mitochondrial encephalopathies. Treatment with folinic acid in addition to supplementation with radical scavengers and cofactors of deficient respiratory enzymes can result in partial clinical improvement and reversal of abnormal myelination patterns on neuro-imaging.
Division of Pediatric Neurology, University Hospital, RWTH Aachen, Germany. vramaekers@skynet.be
V T
VT
Ramaekers
J
J
Weis
J M
JM
Sequeira
E V
EV
Quadros
N
N
Blau
D002648:Child; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D017237:Mitochondrial Encephalomyopathies / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000473:pathology; D013763:Tetrahydrofolates / Q000172:deficiency*; D014803:Vitamin B Complex / Q000627:therapeutic use
D013763:Tetrahydrofolates; C013123:5,10-methylenetetrahydrofolic acid; D014803:Vitamin B Complex; D005492:Folic Acid